Intestinal microbiota, diet and health

British Journal of Nutrition

Volumn 111, Issue 3, 2014, Pages 387-402

  Power, Susan E ^a,b   O'Toole, Paul W ^a,b   Stanton, Catherine ^b,c   Ross, R Paul ^b,c   Fitzgerald, Gerald F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

Author keywords

Diet; Health; Intestinal microbiota; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; CASEIN; DNA 16S; EXOPOLYSACCHARIDE; FAT; FRUCTOSE OLIGOSACCHARIDE; INTERLEUKIN 12; INTERLEUKIN 6; INULIN; POLYSACCHARIDE; PROBIOTIC AGENT; SUGAR; TUMOR NECROSIS FACTOR ALPHA;

AGE; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ATOPOBIUM; BACTERIAL COLONIZATION; BACTERIAL VIABILITY; BACTERIUM TRANSFORMATION; BACTEROIDES CACCAE; BACTEROIDES FRAGILIS; BACTEROIDES OVATUS; BACTEROIDES THETAIOTAOMICRON; BIFIDOBACTERIUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; BLAUTIA HYDROGENOTROPHICA; BREAST MILK; CHEMICAL COMPOSITION; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM LEPTUM; CLOSTRIDIUM SYMBIOSUM; COLLINSELLA AEROFACIENS; CROHN DISEASE; CYTOKINE PRODUCTION; DESULFOVIBRIO PIGER; DIARRHEA; DIET; DIET SUPPLEMENTATION; DRUG EFFICACY; ESCHERICHIA COLI; EUBACTERIUM RECTALE; FAECALIBACTERIUM PRAUSNITZII; FERMENTATION; GESTATIONAL AGE; HEALTH; HORMONE SYNTHESIS; HOSPITALIZATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VIVO STUDY; INFANT FEEDING; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; MACROPHAGE; MARVINBRYANTIA FORMATEXIGENS; METAGENOMICS; MICROBIAL DIVERSITY; MYCOBACTERIUM PARATUBERCULOSIS; NECROTIZING ENTEROCOLITIS; NONHUMAN; OBESITY; POPULATION ABUNDANCE; PROTEIN DEGRADATION; PROTEOBACTERIA; REVIEW; RUMINOCOCCUS; SACCHAROLYTIC BACTERIAL FERMENTATION; SPECIES COMPOSITION; SPECIES DIVERSITY; SPECIES RICHNESS; THERAPY EFFECT; TREATMENT DURATION; ULCERATIVE COLITIS; VEGETARIAN DIET;

AGING; ANIMALS; ANTI-BACTERIAL AGENTS; DIET; DIETARY SUPPLEMENTS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEALTH STATUS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; INTESTINES; IRRITABLE BOWEL SYNDROME; MICROBIAL VIABILITY; MODELS, BIOLOGICAL; PROBIOTICS;

EID: 84893707135     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513002560     Document Type: Review

References (173)

1. O'Hara AM & Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7, 688-693.
2. O'Toole PW & Claesson MJ (2010) Gut microbiota: changes throughout the lifespan from infancy to elderly. Int Dairy J 20, 281-291.
3. Adlerberth I & Wold A (2009) Establishment of the gut microbiota in Western infants. Acta Paediatr 98, 229-238.
4. Rastall RA (2004) Bacteria in the gut: friends and foes and how to alter the balance. J Nutr 134, 2022S-2026S.
5. Dusko Ehrlich S (2010) Metagenomics of the intestinal microbiota: potential applications. Gastroenterol Clin Biol 34, Suppl. 1, S23-S28.
6. Tiihonen K, Ouwehand AC & Rautonen N (2010) Human intestinal microbiota and healthy ageing. Ageing Res Rev 9, 107-116.
7. Isolauri E, Salminen S & Ouwehand AC (2004) Probiotics. Best Pract Res Clin Gastroenterol 18, 299-313.
8. Qin J, Li R, Raes J, et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464, 59-65.
9. Eckburg PB, Bik EM, Bernstein CN, et al. (2005) Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
10. Hold GL, Pryde SE, Russell VJ, et al. (2002) Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol 39, 33-39.
11. Wang X, Heazlewood SP, Krause DO, et al. (2003) Molecular characterization of the microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol 95, 508-520.
12. Hayashi H, Sakamoto M & Benno Y (2002) Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods. Microbiol Immunol 46, 535-548.
13. Tap J, Mondot S, Levenez F, et al. (2009) Towards the human intestinal microbiota phylogenetic core. Environ Microbiol 11, 2574-2584.
14. Rajilić-Stojanović M, Heilig HGHJ, Molenaar D, et al. (2009) Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 11, 1736-1751.
15. Hayashi H, Sakamoto M, Kitahara M, et al. (2003) Molecular analysis of fecal microbiota in elderly individuals using 16S rDNA library and T-RFLP. Microbiol Immunol 47, 557-570.
16. Arumugam M, Raes J, Pelletier E, et al. (2011) Enterotypes of the human gut microbiome. Nature 473, 174-180.
17. Wu GD, Chen J, Hoffmann C, et al. (2011) Linking longterm dietary patterns with gut microbial enterotypes. Science 334, 105-108.
18. Yong E (2012) Gut microbial 'enterotypes' become less clear-cut. Nature News. http://www.nature.com/news (accessed March 2012).
19. Jeffery IB, Claesson MJ, O'Toole PW, et al. (2012) Categorization of the gut microbiota: enterotypes or gradients? Nat Rev Microbiol 10, 591-592.
20. Claesson MJ, Jeffery IB, Conde S, et al. (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488, 178-184.
21. Huse SM, Ye Y, Zhou Y, et al. (2012) A core human microbiome as viewed through 16S rRNA sequence clusters. PLOS ONE 7, e34242.
22. Serino M, Fernández-Real JM, Fuentes EG, et al. (2012) The gut microbiota profile is associated with insulin action in humans. Acta Diabetol (Epublication ahead of print version 19 June 2012).
23. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. (2009) A core gut microbiome in obese and lean twins. Nature 457, 480-484.
24. Biagi E, Candela M, Fairweather-Tait S, et al. (2012) Ageing of the human metaorganism: the microbial counterpart. Age 34, 247-267.
25. Marques TM, Wall R, Ross RP, et al. (2010) Programming infant gut microbiota: influence of dietary and environmental factors. Curr Opin Biotechnol 21, 149-156.
26. Morelli L (2008) Postnatal development of intestinal microflora as influenced by infant nutrition. J Nutr 138, 1791S-1795S.
27. Lupp C & Finlay BB (2005) Intestinal microbiota. Curr Biol 15, 235-236.
28. Grölund MM, Lehtonen OP, Eerola E, et al. (1999) Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J Pediatr Gastroenterol Nutr 28, 19-25.
29. Axad MB, Konya T, Maughan H, et al. (2013) Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. Can Med Assoc J 185, 385-394.
30. Bezirtzoglou E, Tsiotsias A & Welling GW (2011) Microbiota profile in feces of breast-and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 17, 478-482.
31. Penders J, Thijs C, Vink C, et al. (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118, 511-521.
32. Turroni F, Peano C, Pass DA, et al. (2012) Diversity of Bifidobacteria within the infant gut microbiota. PLOS ONE 7, e36957.
33. Yatsunenko T, Rey FE, Manary MJ, et al. (2012) Human gut microbiome viewed across age and geography. Nature 486, 222-227.
34. Favier C, Vaughan E, De Vos WM, et al. (2002) Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 68, 219-226.
35. Yoshioka H, Iseki K & Fujita K (1983) Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics 72, 317-321.
36. Agans R, Rigsbee L, Kenche H, et al. (2011) Distal gut microbiota of adolescent children is different from that of adults. FEMS Microbiol Ecol 77, 404-412.
37. Collins MD & Gibson GR (1999) Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 69, Suppl., 1052S-1057S.
38. Koenig JE, Spor A, Scalfone N, et al. (2011) Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 108, Suppl. 1, 4578-4585.
39. Delgado S, Suárez A & Mayo B (2006) Identification of dominant bacteria in feces and colonic mucosa from healthy Spanish adults by culturing and by 16S rDNA sequence analysis. Dig Dis Sci 51, 744-751.
40. McCartney A, Wenzhi W & Tannock G (1996) Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans. Appl Environ Microbiol 62, 46080-44613.
41. Mueller S, Saunier K, Hanisch C, et al. (2006) Differences in fecal microbiota in different European study populations in relation to age, gender, and country: a cross-sectional study. Appl Environ Microbiol 72, 1027-1033.
42. Claesson MJ, Cusack S, O'Sullivan O, et al. (2011) Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 108, Suppl. 1, 4586-4591.
43. Biagi E, Nylund L, Candela M, et al. (2010) Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5, e10667.
44. Woodmansey E (2007) Intestinal bacteria and ageing. J Appl Microbiol 102, 1178-1186.
45. Cusack S & O'Toole PW (2010) The human intestinal microbiota, diet and health: from infancy to old age. Agro Food Industry Hi-Tech 21, 32-35.
46. Bartosch S, Fite A, Macfarlane GT, et al. (2004) Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using realtime PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol 70, 3575-3581.
47. Flint HJ, Scott KP, Duncan SH, et al. (2012) Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3, 1-18.
48. Fuller R (1991) Probiotics in human medicine. Br Med J 32, 439-442.
49. Scott KP, Duncan SH & Flint HJ (2008) Dietary fibre and the gut microbiota. Nutr Bullet 33, 201-211.
50. Louis P, Scott KP, Duncan SH, et al. (2007) Understanding the effects of diet on bacterial metabolism in the large intestine. J Appl Microbiol 102, 1197-1208.
51. Guarner F & Malagelada JR (2003) Gut flora in health and disease. Lancet 361, 512-519.
52. Apajalahti J (2005) Comparative gut microflora, metabolic challenges, and potential opportunities. J Appl Poult Res 14, 444-453.
53. Kurokawa K, Itoh T, Kuwahara T, et al. (2007) Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 14, 169-181.
54. Flint HJ, Duncan SH, Scott KP, et al. (2007) Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol 9, 1101-1111.
55. Gibson GR (1999) Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr 129, 1438-1441.
56. Roberfroid M (2007) Prebiotics: the concept revisited. J Nutr 137, 830S-837S.
57. Walker AW, Ince J, Duncan SH, et al. (2010) Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 5, 220-230.
58. Hamer HM, Jonkers D, Venema K, et al. (2008) Review Article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27, 104-119.
59. Drasar B, Crowther J, Goddard P, et al. (1973) The relation between diet and the gut microflora in man. Proc Nutr Soc 32, 49-52.
60. Finegold SM, Attebery HR & Sutter VL (1974) Effect of diet on human fecal flora: comparison of Japanese and American diets. Am J Clin Nutr 27, 1456-1469.
61. Drasar B, Jenkins D & Cummings J (1976) The influence of a diet rich in wheat fibre on the human faecal flora. J Med Microbiol 9, 423-431.
62. De Filippo C, Cavalieri D, Di Paola M, et al. (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 107, 14691-14696.
63. Hayashi H, Sakamoto M & Benno Y (2002) Fecal microbial diversity in a strict vegetarian as determined by molecular analysis and cultivation. Microbiol Immunol 46, 819-831.
64. Liszt K, Zwielehner J, Handschur M, et al. (2009) Characterization of bacteria, clostridia and bacteroides in faeces of vegetarians using qPCR and PCR-DGGE fingerprinting. Ann Nutr Metab 54, 253-257.
65. Kabeerdoss J, Devi RS, Mary RR, et al. (2012) Faecal microbiota composition in vegetarians: comparison with omnivores in a cohort of young women in southern India. Br J Nutr 108, 953-957.
66. Zimmer J, Lange B, Frick J, et al. (2011) A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 66, 53-60.
67. Turnbaugh PJ, Ridaura VK, Faith JJ, et al. (2009) The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1, 6ra14.
68. Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. (2009) High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 137, 1716-1724.
69. Faith JJ, McNulty NP, Rey FE, et al. (2011) Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science 333, 101-104.
70. De Palma G, Nadal I, Collado MC, et al. (2009) Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br J Nutr 102, 1154-1160.
71. Muegge BD, Kuczynski J, Knights D, et al. (2011) Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 332, 970-974.
72. Sanz Y (2010) Effects of a gluten-free diet on gut microbiota and immune function in healthy adult humans. Gut Microbes 1, 135-137.
73. Woodmansey EJ, McMurdo MET, Macfarlane GT, et al. (2004) Comparison of compositions and metabolic activities of fecal microbiotas in young adults and in antibiotictreated and non-antibiotic-treated elderly subjects. Appl Environ Microbiol 70, 6113-6122.
74. De La Cochetiere M, Durand T, Lalande V, et al. (2008) Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol 56, 395-402.
75. Young VB & Schmidt TM (2004) Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol 42, 1203-1206.
76. Palmer C, Bik EM, DiGiulio DB, et al. (2007) Development of the human infant intestinal microbiota. PLoS Biol 5, e177.
77. Jernberg C, Löfmark S, Edlund C, et al. (2010) Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 156, 3216-3223.
78. Jernberg C, Löfmark S, Edlund C, et al. (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1, 56-66.
79. Dethlefsen L, Huse S, Sogin ML, et al. (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6, 2383-2400.
80. De La Cochetiere M, Durand T, Lepage P, et al. (2005) Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 43, 5588-5592.
81. Dethlefsen L & Relman DA (2011) Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 108, Suppl. 1, 4554-4561.
82. Jakobsson HE, Jernberg C, Andersson AF, et al. (2010) Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 5, e9836.
83. Croswell A, Amir E, Teggatz P, et al. (2009) Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect Immun 77, 2741-2753.
84. Antunes LCM, Han J, Ferreira RBR, et al. (2011) Effect of antibiotic treatment on the intestinal metabolome. Antimicrob Agents Chemother 55, 1494-1503.
85. Fouhy F, Guinane CM, Hussey S, et al. (2012) High-throughput sequencing reveals the incomplete, short-term, recovery of the infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother 56, 5811-5820.
86. Hussey S, Wall R, Gruffman E, et al. (2011) Parenteral antibiotics reduce bifidobacteria colonization and diversity in neonates. Int J Microbiol 2011, 130574.
87. Russell SL, Gold MJ, Hartmann M, et al. (2012) Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep 13, 440-447.
88. Foliaki S, Pearce N, Björkstén B, et al. (2009) Antibiotic use in infancy and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old: International Study of Asthma and Allergies in Childhood Phase III. J Allergy Clin Immunol 124, 982-989.
89. Sekirov I, Russell SL, Antunes LCM, et al. (2010) Gut microbiota in health and disease. Physiol Rev 90, 859-904.
90. Vanderhoof JA, Whitney DB, Antonson DL, et al. (1999) Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 135, 564-568.
91. Ojetti V, Gigante G, Ainora M, et al. (2009) Microflora imbalance and gastrointestinal diseases. Dig Liver Dis Suppl 3, 35-39.
92. Isaacs K & Herfarth H (2008) Role of probiotic therapy in IBD. Inflamm Bowel Dis 14, 1597-1605.
93. Reiff C & Kelly D (2010) Inflammatory bowel disease, gut bacteria and probiotic therapy. Int J Med Microbiol 300, 25-33.
94. Gerritsen J, Smidt H, Rijkers GT, et al. (2011) Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 6, 209-240.
95. Dicksved J & Willing B (2011) The role of dysbiosis in inflammatory bowel diseases. In Handbook of Molecular Microbial Ecology II: Metagenomics in Different Habitats, pp. 199-206 [FJ de Bruijn, editor]. Hoboken, NJ: John Wiley & Sons, Inc.
96. Shanahan F (2010) 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: host-microbe interactions in the gut: target for drug therapy, opportunity for drug discovery. Clin Exp Immunol 160, 92-97.
97. Sokol H, Pigneur B, Watterlot L, et al. (2008) Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 105, 16731-16736.
98. Malinen E, Rinttilä T, Kajander K, et al. (2005) Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 100, 373-382.
99. Madden J (2004) The intestinal microbiota and probiotics in irritable bowel syndrome. Food Nutr Res 48, 32-36.
100. Jeffery IB, O'Toole PW, Ö hman L, et al. (2011) An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61, 997-1006.
101. Carroll IM, Ringel-Kulka T, Keku TO, et al. (2011) Molecular analysis of the luminal-and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 301, G799-G807.
102. Andresen V & Baumgart DC (2006) Role of probiotics in the treatment of irritable bowel syndrome: potential mechanisms and current clinical evidence. Int J Prob Preb 1, 11-18.
103. Quigley EMM (2007) Probiotics in irritable bowel syndrome: an immunomodulatory strategy? J Am Coll Nutr 26, 684S-690S.
104. Thabane M, Kottachchi D & Marshall J (2007) Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 26, 535-544.
105. Mättö J, Maunuksela L & Kajander K (2005) Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 43, 213-222.
106. Maukonen J, Satokari R, Mättö J, et al. (2006) Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 55, 625-633.
107. Codling C, O'Mahony L & Shanahan F (2010) A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 55, 392-397.
108. Carroll I, Ringel Kulka T, Siddle J, et al. (2012) Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 24, 521-530.
109. Bäckhed F, Ding H, Wang T, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 101, 15718-15723.
110. Bäckhed F, Manchester JK, Semenkovich CF, et al. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 104, 979-984.
111. Turnbaugh PJ, Ley RE, Mahowald MA, et al. (2006) An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
112. Cani PD, Amar J, Iglesias MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772.
113. Wellen KE & Hotamisligil GS (2005) Inflammation, stress and diabetes. J Clin Invest 115, 1111-1119.
114. Erridge C, Attina T, Spickett CM, et al. (2007) A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 86, 1286-1292.
115. Ghoshal S, Witta J, Zhong J, et al. (2009) Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50, 90-97.
116. Brun P, Castagliuolo I, Leo VD, et al. (2007) Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 292, 518-525.
117. Cani PD, Possemiers S, Van de Wiele T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103.
118. Sommer F & Bäckhed F (2013) The gut microbiota-masters of host development and physiology. Nat Rev Microbiol 11, 227-238.
119. Duncan SH, Lobley GE, Holtrop G, et al. (2008) Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes 32, 1720-1724.
120. Ley RE, Bäckhed F, Turnbaugh P, et al. (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102, 11070-11075.
121. Ley RE, Turnbaugh PJ, Klein S, et al. (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
122. Zhang H, DiBaise JK, Zuccolo A, et al. (2009) Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 106, 2365-2370.
123. Schwiertz A, Taras D, Schafer K, et al. (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18, 190-195.
124. Duncan S, Belenguer A, Holtrop G, et al. (2007) Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrateproducing bacteria in feces. Appl Environ Microbiol 73, 1073-1078.
125. Joint FAO/WHO Working Group (2002) Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London/Ontario/Canada: FAO/WHO.
126. Metchnikoff E (1908) The Prolongation of Life. New York/London: Putnam's Sons.
127. Ouwehand AC, Salminen S & Isolauri E (2002) Probiotics: an overview of beneficial effects. Antonie van Leeuwenhoek 82, 279-289.
128. Parvez S, Malik K, Ah Kang S, et al. (2006) Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 100, 1171-1185.
129. Vanderhoof JA & Young R (2008) Probiotics in the United States. Clin Infect Dis 46, Suppl. 1, S67-S72.
130. Goldin BR (2011) Probiotics and health: from history to future. In Probiotics and Health Claims, 1st ed. [W Kneifel and S Salminen, editors]. Oxford: Wiley-Blackwell.
131. Videlock E & Cremonini F (2012) Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 35, 1355-1369.
132. Allen SJ, Martinez EG, Gregorio GV, et al. (2011) Probiotics for treating acute infectious diarrhoea. The Cochrane Database of Systematic Reviews, issue 11, CD003048.
133. Hempel S, Newberry SJ, Maher AR, et al. (2012) Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 307, 1959-1969.
134. Bernaola Aponte G, Bada Mancilla CA, Carreazo Pariasca NY, et al. (2010) Probiotics for treating persistent diarrhoea in children. The Cochrane Database of Systematic Reviews, issue 11, CD007401.
135. AlFaleh K, Anabrees J & Bassler D (2010) Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology 97, 93-99.
136. Johnston B, Supina A, Ospina M, et al. (2007) Probiotics for the prevention of pediatric antibiotic-associated diarrhea. The Cochrane Database of Systematic Reviews, issue 2, CD004827.
137. Barclay AR, Stenson B, Simpson JH, et al. (2007) Probiotics for necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr 45, 569-576.
138. Wang Q, Dong J & Zhu Y (2012) Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated metaanalysis of 20 randomized, controlled trials. J Pediatr Surg 47, 241-248.
139. O'Toole PW & Cooney JC (2008) Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdiscip Perspect Infect Dis (epublication 3 December 2008).
140. Tuohy KM, Probert HM, Smejkal CW, et al. (2003) Using probiotics and prebiotics to improve gut health. Drug Discov Today 8, 692-700.
141. Sanders ME, Heimbach JT, Pot B, et al. (2011) Health claims substantiation for probiotic and prebiotic products. Gut Microbes 2, 127-133.
142. Anderson J, Edney R & Whelan K (2012) Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 36, 503-516.
143. Guo B, Harstall C, Louie T, et al. (2012) Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 35, 865-875.
144. Landy J, Al-Hassi H, McLaughlin S, et al. (2011) Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther 34, 409-415.
145. Kailasapathy K & Chin J (2000) Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 78, 80-88.
146. Shah NP, Lankaputhra WEV, Britz ML, et al. (1995) Survival of Lactobacillus acidophilus and Bifidobacterium bifidum in commercial yoghurt during refrigerated storage. Int Dairy J 5, 515-521.
147. Adams CA (2010) The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 23, 37-46.
148. Kataria J, Li N, Wynn JL, et al. (2009) Probiotic microbes: do they need to be alive to be beneficial? Nutr Rev 67, 546-550.
149. Lopez M, Li N, Kataria J, et al. (2008) Live and ultravioletinactivated Lactobacillus rhamnosus GG decrease flagellin-induced interleukin-8 production in Caco-2 cells. J Nutr 138, 2264-2268.
150. Taverniti V & Guglielmetti S (2011) The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept). Genes Nutr 6, 261-274.
151. Lammers KM, Brigidi P, Vitali B, et al. (2003) Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells. FEMS Immunol Med Microbiol 38, 165-172.
152. Rachmilewitz D, Katakura K, Karmeli F, et al. (2004) Tolllike receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126, 520-528.
153. Hosono A, Lee J, Ametani A, et al. (1997) Characterization of a water-soluble polysaccharide fraction with immunopotentiating activity from Bifidobacterium adolescentis M101-4. Biosci Biotechnol Biochem 61, 312-316.
154. Dalpke AH, Frey M, Morath S, et al. (2002) Interaction of lipoteichoic acid and CpG-DNA during activation of innate immune cells. Immunobiology 206, 392-407.
155. Zhang L, Li N, Caicedo R, et al. (2005) Alive and dead Lactobacillus rhamnosus GG decrease tumor necrosis factor-alpha-induced interleukin-8 production in Caco-2 cells. J Nutr 135, 1752-1756.
156. Li N, Russell WM, Douglas-Escobar M, et al. (2009) Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res 66, 203-207.
157. Matsuguchi T, Takagi A, Matsuzaki T, et al. (2003) Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Vaccine Immunol 10, 259-266.
158. Ciszek-Lenda M, Nowak B, Śróttek M, et al. (2011) Immunoregulatory potential of exopolysaccharide from Lactobacillus rhamnosus KL37. Effects on the production of inflammatory mediators by mouse macrophages. Int J Exp Pathol 92, 382-391.
159. Wu MH, Pan TM, Wu YJ, et al. (2010) Exopolysaccharide activities from probiotic bifidobacterium: immunomodulatory effects (on J774A. 1 macrophages) and antimicrobial properties. Int J Food Microbiol 144, 104-110.
160. Arena A, Maugeri TL, Pavone B, et al. (2006) Antiviral and immunoregulatory effect of a novel exopolysaccharide from a marine thermotolerant Bacillus licheniformis. Int Immunopharmacol 6, 8-13.
161. Hidalgo-Cantabrana C, López P, Gueimonde M, et al. (2012) Immune modulation capability of exopolysaccharides synthesised by lactic acid bacteria and bifidobacteria. Probiotics Antimicrob Proteins 4, 227-237.
162. López P, Monteser?́n DC, Gueimonde M, et al. (2012) Exopolysaccharide-producing Bifidobacterium strains elicit different in vitro responses upon interaction with human cells. Food Res Int 46, 99-107.
163. Fanning S, Hall LJ, Cronin M, et al. (2012) Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci USA 109, 2108-2113.
164. Hiramatsu Y, Hosono A, Takahashi K, et al. (2007) Bifidobacterium components have immunomodulatory characteristics dependent on the method of preparation. Cytotechnology 55, 79-87.
165. Xiao SD, Zhang DZ, Lu H, et al. (2002) Multicenter randomized controlled trial of heat killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Chin J Dig Dis 3, 167-171.
166. Halpern GM, Prindiville T, Blankenburg M, et al. (1996) Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 91, 1579-1585.
167. Chauvière G, Coconnier MH, Kerneis S, et al. (1992) Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heatkilled Lactobacillus. FEMS Microbiol Lett 91, 213-217.
168. Arribas B, Garrido-Mesa N, Perán L, et al. (2011) The immunomodulatory properties of viable Lactobacillus salivarius ssp. salivarius CECT5713 are not restricted to the large intestine. Eur J Nutr 51, 365-374.
169. Ma D, Forsythe P & Bienenstock J (2004) Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 72, 5308-5314.
170. Zoetendal EG, Rajilic-Stojanovic M & de Vos WM (2008) High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Br Med J 57, 1605-1615.
171. Bermudex-Brito M, Plaza-D?́az J, Fontana L, et al. (2013) In vitro cell and tissue models for studying host-microbe interactions: a review. Br J Nutr 109, Suppl. 2, 23-34.
172. Shanahan F (2010) The year in gastroenterology: probiotics in perspective. Gastroenterology 139, 1808-1812.
173. Dominguez-Bello MG, Costello EK, Contreras M, et al. (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 107, 11971-11975.